Effect of dietetic supplementation with L-arginine in cancer patients. A review of the literature;Efeitos da suplementação dietética com L-arginina no paciente oncológico. Uma revisão de literatura

Archivos Latinoamericanos de Nutricion

Volumn 49, Issue 4, 1999, Pages 301-308

  Novaes, Maria Rita C G ^a   Lima, Luiz Alberto M ^a  

^a NONE

Author keywords

Arginine; Cancer; Dietary supplementation

Indexed keywords

ARGININE;

ANIMAL; DIET SUPPLEMENTATION; HUMAN; IMMUNOLOGY; NEOPLASM; NUTRITIONAL DISORDER; REVIEW;

ANIMALS; ARGININE; DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS; NUTRITION DISORDERS;

EID: 0040715962     PISSN: 00040622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. World Health Organization (WHO). The World Health Report. Geneve 1998: 5-203.
2. Warren S. The Immediate Causes Of Death In Cancer. Am J Med Sci. 1932;184:610.
3. Boente PC, Brandão MR, Aguiar ER & Sampaio C. Terapia Nutricional Em Pacientes Oncológicos. Rev Bras Nutr Clin. 1997;12: 49-54.
4. Kern KA & Norton JA. Cancer Cachexia. J Parenteral Enteral Nutr. 1988;12:28-95.
5. Mainous MR & Deitch E. Nutrition And Infection. Surg Clin North Am. 1994;74(3):659-676.
6. Kirk SJ & Barbul A. Role Of Arginine In Trauma, Sepsis And Immunity. J Parenteral Enteral Nutr. 1990; 14(5):226s-229s.
7. Oka T, Ohwada K, Mitsuhiro N & Kitazato K. Effect Of Arginine-Enriched Total Parenteral Nutrition On The Host-Tumor Interaction In Cancer-Bearing Rats. J Par Enter Nutr. 1993; 17(4): 375-383.
8. Pisters PW & Pearlstone DB. Protein And Amino Acid Metabolism In Cancer Cachexia: Investigative Techniques And Therapeutic Interventions. Crit Rev In Clin Lab Sciences. 1993; 30(3):223-272.
9. Mitchell EP & Schein PS. Gastrointestinal Toxicity Of Chemotherapeutic Agents. Semin Oncol. 1982; 9:52.
10. Furst P. New Parenteral Substrates In Clinical Nutrition. Part I Introduction. New Substrates In Protein Nutrition. Eur J Clin Nutr. 1994; 48(9):607-616.
11. Brittenden J, Heys SD & Eremin O, L-Arginine And Malignant Disease: A Potential Therapeutic Role? European Journal Of Surgical Oncology. 1994; 20:189-92.
12. Kemen M, Senkal M, Homann HH, Mumme A, Dauph AK, Baier J, Windele J, Neumann H & Zumtobel V. Early Post-Operative Enteral Nutrition With Arginine-ω-3 Fatty Acids And Ribonucleid Acid-Supplemented Diet Versus Placebo In Cancer Patients: An Immunologic Evaluation Of Impact. Crit Care Med. 1995; 23(4):652-659.
13. Langstein NH & Norton JA. Mechanisms Of Cancer Cachexia. Hematol/Oncol. Cin Nutr Am. 1991; 5:103-123.
14. Stovroff MC, Fraker DL, Swedenborg JA & Norton JA. Cachectin/Tumor Necrosis Factor: A Possible Mediator Of Cancer Anorexia In The Rat. Cancer Research. 1988;48:4567-4572.
15. Bach JS & Lasnitzki I. Some Aspects Of The Role Of Arginine And Arginase In Mouse Carcinoma 63. Enzymology. 1953; 12:198-205.
16. Levy HM, Montanez G & Feaver ER. Effect Of Arginine On Tumor Growth In Rats. Cancer Res. 1954; 14: 198-200.
17. Seifter E, Rettura G & Barbul A. Arginine: An Essential Amino Acid For Injured Rats. Surgery. 1978; 84:224-230.
18. Featherston WR, Rogers QR & Freedland RA. Relative Importance Of Kidney And Liver In Synthesis Of Arginine By The Rat. Am J Physiol. 1973;224(1):127-129.
19. Borman A, Wood TR, Black HC, Anderson EG, Oesterling MJ, Womack M & Rose WC. The Role Of Arginine In Growth With Some Observations On The Effect Of Arginic Acid. J Biol Chem. 1946;166: 585-594.
20. Heys SD, Segar A, Payne S, Bruce DM, Kernohan N & Eremin O. Dietary Supplementation With L-Arginine: Modulation Of Tumor-Infiltrating Lymphocytes In Patients With Colorectal Cancer. British Journal Of Surgery. 1997; 84:238-241.
21. Tozer GM, Prise VE & Chaplin DJ. Inhibition Of Nitric Oxide Synthase Induces A Selective In Tumor Blood Flow That Is Reversible With L-Arginine. Cancer Research. 1997; 57:948-955.
22. Debiasse MA & Wilmore DW. What Is Optimal Nutrition Support? New Horiz. 1994; 2 (2):122-130.
23. Beard HH. The Effect Of Parenteral Injection Of Synthetic Amino Acids Upon The Appearence, Growth And Disappearance Of Emge Sarcoma In Rats. Arch Biochem. 1943;1:177-186.
24. Cho-Chung YS, Clair T & Bodwin JS. Arrest Of Mammary Tumor In vivo By L-Arginine: Stimulation Of NAD-Dependent Activation Of Adenylate Cyclase. Biochem Biophy Res Commun. 1980; 95:1306-1310.
25. Weisburger JH, Yamamoto RS & Glass RM. Prevention By Arginine Glutamate Of The Carcinogenicity Of Acetamide In Rats. Toxicol Appl Pharmacol. 1969;14:163.
26. Takeda Y, Tominaga T & Tei N. Inhibitory Effect Of L-Arginine On Growth Of Rat Mammary Tumors Induced By 7/ 12-Dimethylbenzyl Antracene. Cancer Res. 1975; 35(9):2390-2393.
27. Ma Q, Hoper M, Anderson N & Rowlands BJ. Effect Of Supplemental L-Arginine In A Chemical-Induced Model Of Colorectal Cancer. World J Surg. 1996; 20:1087-1091.
28. Milner JA & Stepanovich LV. Inhibitor Effect Of Dietary Arginine On Growth Of Ehrlich Ascites Tumor Cells In Mice. J Nutr. 1979; 109(3):489-494.
29. Pryme IF. The Failure Of Growth Of A Mouse Myeloma Tumor During The Course Of Oral Administration Of L-Arginine-Hydrochloride. Cancer Lett. 1978;5(1):19-23.
30. Tachibana L, Mukai K, Moriguchi S, Takama, S & Kishino Y. Evaluation Of The Effect Of Arginine-Enriched Amino Acid Solution On Tumor Growth. J Parenter Enterai Nutr. 1985; 9:428-434.
31. Hester JE & Fee WE. Effect Of Arginine On Growth Of Squamous Cell Carcinoma In The C3h/Km Mouse. Arch. Otolaryngol. Head Neck Surg. 1995; 121 (2): 193-196.
32. Edwards PD, Topping D, Kontaridis MI, Moldawer LL, Copeland EM & Lind DS. Arginine-Enhance Enterai Nutrition Augments The Growth Of A Nitric Oxide-Producing Tumor. J Parenteral Enterai Nutr. 1997; 21(4): 215-219.
33. Yeatman JT, Risley GL & Brunson ME. Depletion Of Dietary Arginine Inhibts Growth Of Metastatic Tumor Arch Surg. 1991;126:1376-1382.
34. Grossie VB Jr. Citrulline And Arginine Increase The Growth Of The Ward Colon Tumor In Parenterally Fed Rats. Nutr Cancer. 1996; 26(1):91-97.
35. Grossie VB Jr, Nishioka K, Ajani JA & Ota DM. Substituting Ornithine For Arginine In Total Parenteral Nutrition Eliminates Enhanced Tumor Growth. J Surg Oncol. 1992; 50(3): 161-167.
36. Barbul A, Wasserkrug HL & Feaver ER. Immunostimulatory Effects Of Arginine In Normal And Injured Rats. J Surg Res. 1980; 29:223-227.
37. Barbul A. Arginine: Biochemistry, Physiology And Therapeutic Implications. J Parenter Enterai Nutr. 1986;10:227-238.
38. Hibbs JB, Vavrin Z & Taintor RR. L-Arginine Is Required For Expression Of The Activated Macrophage Effector Mechanism Causing Selective Metabolic Inhibition In Target Cells. J Immunol. 1987; 138:550-555.
39. Reynolds JV, Daly JM, Shou J, Sigal R, Ziegler MM & Naji A. Immunological Effects Of Arginine Supplementation In Tumor Bearing And Non Tumor Bearing Hosts. Ann Surg. 1990; 211:202-210.
40. Saito H, Trocki O, Wang S, Gonce SJ, Joffe SN & Alexander JW. Metabolic And Immune Effects Of Dietary Arginine Supplementation After Burn. Arch Surg. 1987; 122:784-789.
41. Ziegler TR, Gatzen C & Wilmore DW. Strategies For Attenuating Protein-Catabolic Responses In The Critically Ill. Annu Rev. Med. 1994; 45:459-480.
42. Sigal RK, Shou J & Daly JM. Parenteral Arginine Infusion In Humans: Nutrient Substrate Or Pharmacologic Agent? J Parenter Enterai Nutr. 1992;16(5):423-428.
43. Park KGM, Hayes PD, Garlick PJ, Sewell H & Eremin O. Stimulation Of Lymphocyte Natural Cytotoxity By L-Arginine. Lancet. 1991; 337:645-646.
44. Senkal M., Kernen M, Homann HH, Eickhoff U, Baier J & Zumtobel V. Modulation Of Postoperative Immune Response By Enteral Nutrition With A Diet Enriched With Arginine, RNA, And Omega-3 Fatty Acids In Patients With Upper Gastrointestinal Cancer. Eur J Surg. 1995; 161(2):115-122.
45. Saunders C, Nishikama R & Wolfe B. Surgical Nutrition: A Review. J. R. Coll Surg Edin. 1993; 38(4):195-204.
46. Heyland DK, Cook DJ & Guyatt GH Does The Formulation Of Enterai Feeding Products Influence Infectious Morbidity And Mortality Rates In The Critically Ill Patient? A Critical Review Of The Evidence. Crit Care Med. 1994; 22(7):1192-1202.
47. Daly JM, Weintraub FN, Shou J, Rosato EF & Lucia M. Enteral Nutrition During Multimodality Therapy In Upper Gastrointestinal Cancer Patients. Ann Surg. 1995; 221(4):327-338.
48. Bower RH, Cerra FB & Bershadsky B. Early Enteral Administration Of A Formula (Impact) Supplemented With Arginine Nucleotides And Fish Oil In Intensive Care Unit Patients: Results Of A Multicenter Prospective Randomised Clinical Trial. Crit Care Med. 1995; 23:436-449.
49. Braga M. Artificial Nutrition After Major Abdominal Surgery: Impact Of Route Of Administration And Composition Of The Diet. Crit Care Med. 1998; 26(1): 24-30.
50. Ford C, Whitlock JA & Pietsch JB. Glutamine-Supplemented Tube Feedings Versus Total Parenteral Nutrition In Children Receiving Intensive Chemotherapy. J Pediatr Oncol Nurs. 1997;14(2):68-72.
51. Theologides, A. Pathogenesis Of Caquexia In Cancer: A Review And A Hypothesis. Cancer. 1972; 20:484-488.
52. Grant JP. Nutrition Support In Critically Ill Patients. Ann Surg. 1994; 220(5):610-616.
53. Konur A, Krause SW, Reahli M, Kreutz M & Andreesen R. Human Monocytes Induce A Carcinoma Cell Line To Secrete High Amounts Of Nitric Oxide. Journal of Immunology. 1996; 2110-2115.
54. Carmo A, Lopes C, Santos M, Proença R, Cunha-Vaz J & Carvalho A. Nitric Oxide Synthase Activity And L-Arginine Metabolism In The Retinas From Streptozotocin-Induced Diabetic Rats. General Pharmacology. 1998; 30(3):319-324.